Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Weldon Mauney
Observed name:
Mauney Weldon
OpenAlex ID:
A5034202437
Final results from a Phase 3, long‐term, open‐label, repeat‐dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsy
2021
·
James W. Wheless
, Ian Miller
, et al.
·
Epilepsia
·
79
Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial
2023
·
Prasanna Jagannathan
, Kara W. Chew
, et al.
·
EClinicalMedicine
·
14
Consistent safety and tolerability of Valtoco® (diazepam nasal spray) in relationship to usage frequency in patients with seizure clusters: Interim results from a phase 3, long‐term, open‐label, repeat‐dose safety study
2021
·
Ian Miller
, James W. Wheless
, et al.
·
Epilepsia Open
·
10
PDF
Safety and Tolerability of NRL-1, an Intranasal Formulation of Diazepam, in Relationship to Usage Frequency in Subjects With Epilepsy: Interim Results From a Phase 3, Open-label, Repeat Dose Study (1992)
2020
·
Ian Miller
, James W. Wheless
, et al.
·
Neurology
·
2
Effectiveness and Safety of Valtoco® (NRL-1; diazepam nasal spray) in Patients With Epilepsy and a History of Seasonal Allergies: Interim Results From a Phase 3, Open-Label, 12-Month Repeat Dose Study (2048)
2020
·
Blanca Vazquez
, Michael R. Sperling
, et al.
·
Neurology
Show more works
View as search
Works count:
5
Citation count:
105
H-index:
3
I10-index:
3
Year
Topic
Type